Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin
Top Cited Papers
Open Access
- 1 August 2008
- journal article
- review article
- Published by Elsevier in Journal of Hepatology
- Vol. 49 (2) , 274-287
- https://doi.org/10.1016/j.jhep.2008.05.002
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis CJournal of Hepatology, 2007
- Efficacy of Antiviral Therapy on Hepatitis C Recurrence After Liver Transplantation: A Randomized Controlled StudyGastroenterology, 2007
- Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantationLiver Transplantation, 2006
- Hepatitis C Recurrence After Liver Transplantation: Viral and Histologic Response to Full-Dose Peg-Interferon and RibavirinAmerican Journal of Transplantation, 2006
- Report of the Monothematic EASL Conference on Liver Transplantation for Viral HepatitisJournal of Hepatology, 2006
- Combined treatment with pegylated interferon (α-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantationJournal of Hepatology, 2005
- Applicability, Tolerability and Efficacy of Preemptive Antiviral Therapy in Hepatitis C-Infected Patients Undergoing Liver TransplantationAmerican Journal of Transplantation, 2005
- Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combinationJournal of Hepatology, 2004
- Prophylactic and preemptive therapies for hepatitis C virus-infected patients undergoing liver transplantationLiver Transplantation, 2003
- Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantationJournal of Hepatology, 2003